Atlas Trials

A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma

Clinical trial NCT00684827 · COMPLETED

Trial details

NCT number
NCT00684827
Sponsor
Sumitomo Pharma America, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2002-10-01
Primary completion
2003-02-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.